OSM
Oncostatin-M
Also known as: MGC20461, ONCM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13725
- Gene
- OSM
- Ensembl
- ENSG00000099985
- Chromosome
- 22
- Canonical length
- 252 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the leukemia inhibitory factor/oncostatin-M (LIF/OSM) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a secreted cytokine and growth regulator that inhibits the proliferation of a number of tumor cell lines. This protein also regulates the production of other cytokines, including interleukin 6, granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in endothelial cells. This gene and the related gene, leukemia inhibitory factor, also present on chromosome 22, may have resulted from the duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
252 residues, UniProt reviewed canonical sequence.
>P13725|OSM
1 MGVLLTQRTL LSLVLALLFP SMASMAAIGS CSKEYRVLLG QLQKQTDLMQ DTSRLLDPYI
61 RIQGLDVPKL REHCRERPGA FPSEETLRGL GRRGFLQTLN ATLGCVLHRL ADLEQRLPKA
121 QDLERSGLNI EDLEKLQMAR PNILGLRNNI YCMAQLLDNS DTAEPTKAGR GASQPPTPTP
181 ASDAFQRKLE GCRFLHGYHR FMHSVGRVFS KWGESPNRSR RHSPHQALRK GVRRTRPSRK
241 GKRLMTRGQL PRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OSM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 112 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 112 nTPM
- appendix: 14 nTPM
- urinary bladder: 12 nTPM
- lung: 7.6 nTPM
- adipose tissue: 6.8 nTPM
- gallbladder: 5.8 nTPM
Single-cell type
- neutrophils: 519 nCPM
- monocytes: 80 nCPM
- hofbauer cells: 46 nCPM
- macrophages: 42 nCPM
- cdc: 19 nCPM
- mast cells: 19 nCPM
Immune cell
- basophil: 66 nTPM
- neutrophil: 35 nTPM
- MAIT T-cell: 6.5 nTPM
- memory CD4 T-cell: 4.8 nTPM
- NK-cell: 4.3 nTPM
- memory CD8 T-cell: 2.6 nTPM
Brain region
- thalamus: 8.3 nTPM
- cerebral cortex: 5.8 nTPM
- white matter: 4.9 nTPM
- choroid plexus: 3.6 nTPM
- medulla oblongata: 2.9 nTPM
- pons: 2.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OSM.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 62 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.59
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- immune response
- negative regulation of cell population proliferation
- negative regulation of hormone secretion
- oncostatin-M-mediated signaling pathway
- positive regulation of acute inflammatory response
- positive regulation of cell division
- positive regulation of cell population proliferation
- positive regulation of inflammatory response
- positive regulation of interleukin-17 production
- positive regulation of MAPK cascade
- positive regulation of peptidyl-serine phosphorylation
- positive regulation of peptidyl-tyrosine phosphorylation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of transcription by RNA polymerase II
- positive regulation of tyrosine phosphorylation of STAT protein
- regulation of hematopoietic stem cell differentiation
Molecular functions
- cytokine activity
- growth factor activity
- oncostatin-M receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OSM as an antibody target. Whether an autoantibody or antibody against OSM could matter depends on whether native OSM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OSM is annotated as secreted, so native OSM circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label OSM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...